Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-5-16
pubmed:abstractText
To determine whether amelioration of insulin resistance in polycystic ovary syndrome (PCOS) with the insulin sensitizer troglitazone (TGZ) decreases circulating adrenal androgens (AAs), as reflected by DHEAS levels.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0015-0282
pubmed:author
pubmed:issnType
Print
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
932-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12749433-Adrenal Glands, pubmed-meshheading:12749433-Adult, pubmed-meshheading:12749433-Blood Glucose, pubmed-meshheading:12749433-Chromans, pubmed-meshheading:12749433-Dehydroepiandrosterone Sulfate, pubmed-meshheading:12749433-Dose-Response Relationship, Drug, pubmed-meshheading:12749433-Double-Blind Method, pubmed-meshheading:12749433-Female, pubmed-meshheading:12749433-Glucose Tolerance Test, pubmed-meshheading:12749433-Humans, pubmed-meshheading:12749433-Hyperandrogenism, pubmed-meshheading:12749433-Hyperinsulinism, pubmed-meshheading:12749433-Hypoglycemic Agents, pubmed-meshheading:12749433-Insulin, pubmed-meshheading:12749433-Insulin Resistance, pubmed-meshheading:12749433-Polycystic Ovary Syndrome, pubmed-meshheading:12749433-Prospective Studies, pubmed-meshheading:12749433-Thiazoles, pubmed-meshheading:12749433-Thiazolidinediones
pubmed:year
2003
pubmed:articleTitle
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
pubmed:affiliation
Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama, USA. azzizr@cshs.org
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study